JO
ASPX

John Overdeck’s AUSPEX PHARMACEUTICALS INC COM STK (DE) ASPX Stock Holding History

John Overdeck’s Portfolio ASPX Stock Details ASPX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-7,800
Closed -$409K – 3095
2014
Q4 		$409K Buy
+7,800
New +$229K ﹤0.01% 1810

Other funds holding ASPX

DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return
WIC
Water Island Capital New York $1.08B AUM 105.75% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

John Overdeck's ASPX Position: Q1 2015 in Review

John Overdeck sold out of AUSPEX PHARMACEUTICALS INC COM STK (DE) (ASPX) in Q1 2015, closing a stake of 7,800 shares — an estimated $409K sold.

John Overdeck first reported a position in ASPX in Q4 2014 and held it in 1 quarter. The position peaked at $409K in Q4 2014. 138 funds tracked by Wall St. Rank hold ASPX as of Q1 2015.

  • John Overdeck reported no remaining AUSPEX PHARMACEUTICALS INC COM STK (DE) position as of Q1 2015 after selling out during the quarter.
  • John Overdeck sold 7,800 AUSPEX PHARMACEUTICALS INC COM STK (DE) shares in Q1 2015, an estimated $409K.
  • John Overdeck first reported a position in AUSPEX PHARMACEUTICALS INC COM STK (DE) in Q4 2014 and held it in 1 quarter.
  • John Overdeck's AUSPEX PHARMACEUTICALS INC COM STK (DE) position peaked at $409K in Q4 2014.
  • 138 funds tracked by Wall St. Rank held AUSPEX PHARMACEUTICALS INC COM STK (DE) as of Q1 2015.

Based on Two Sigma Investments's 13F filing for Q1 2015, filed 15 May 2015.